Glucose and Sucrose Assay Kit |
GWB-AXR286 |
GenWay Biotech |
100 assays |
Ask for price |
Biomarker Assay Laboratories manufactures the fda approval of biomarker assay reagents distributed by Genprice. The Fda Approval Of Biomarker Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact biomarker assay. Other Fda products are available in stock. Specificity: Fda Category: Approval Group: Of Biomarker
Lactic Acid Assay, Colorimetric/Fluorometric Assay |
Tribioscience |
100 tests |
EUR 320 |
Creatinine Assay Kit (urine normalizing assay) |
MyBiosource |
1Kit |
EUR 220 |
Creatinine Assay Kit (urine normalizing assay) |
MyBiosource |
5x1Kit |
EUR 960 |
Of Biomarker information
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381128-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381128-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381128-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381129-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381129-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381129-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381129-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker) |
MBS4381129-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 1mg/mL |
BNUM1943-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL |
BNUB1943-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL |
BNUB1943-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 1mg/mL |
BNUM2430-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL |
BNUB2430-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL |
BNUB2430-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 1mg/mL |
BNUM2759-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 1mg/mL |
BNUM2760-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL |
BNUB2759-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |